PollyNSatcherayted's blog

Micro Invasive Glaucoma Surgery MIGS Devices Market Focuses on Market Share, Size and Projected Forecast Till 2031

PollyNSatcherayted's photo
PollyNSatcherayted
·

4 min read

Executive Summary

The global Micro Invasive Glaucoma Surgery (MIGS) Devices market research reports indicate a significant growth trajectory with a projected Compound Annual Growth Rate (CAGR) of % during the forecasted period. MIGS devices offer a minimally invasive option for the treatment of glaucoma, which is a leading cause of blindness worldwide. The growing prevalence of glaucoma, coupled with increasing awareness about the benefits of MIGS procedures, is driving the market growth.

Market trends in the MIGS devices sector include technological advancements leading to the development of more efficient and safer devices, increasing adoption of MIGS procedures by ophthalmologists, and collaborations between key players to expand their product portfolios. The market is also witnessing a rise in strategic initiatives such as mergers, acquisitions, and partnerships to gain a competitive edge in the market.

Geographically, the MIGS devices market is segmented into North America (NA), Asia Pacific (APAC), Europe, United States (USA), and China. North America currently dominates the market due to the presence of a well-established healthcare infrastructure, increasing prevalence of glaucoma, and a favorable reimbursement scenario. The Asia Pacific region is expected to witness significant growth in the coming years, driven by a rising geriatric population, increasing healthcare expenditure, and growing awareness about eye health.

In conclusion, the global Micro Invasive Glaucoma Surgery (MIGS) Devices market is poised for substantial growth fueled by technological advancements, increasing prevalence of glaucoma, and expanding adoption of minimally invasive procedures. Key market players are focusing on innovation and strategic collaborations to capitalize on the growing demand for MIGS devices globally.

Get a Sample PDF of the Report: https://www.reportprime.com/enquiry/request-sample/9730

Market Segmentation:

This Micro Invasive Glaucoma Surgery MIGS Devices Market is further classified into Overview, Deployment, Application, and Region. 

In terms of Components, Micro Invasive Glaucoma Surgery MIGS Devices Market is segmented into:

  • Glaukos Corporation
  • Ivantis
  • Allergan
  • Ellex
  • Alcon
  • BVI
  • Johnson and Johnson Surgical Vision
  • Microsurgical Technology
  • Iridex
  • New World Medical
  • Santen Pharmaceutical
  • Sight Scientific

https://www.reportprime.com/micro-invasive-glaucoma-surgery-migs-devices-r9730

The Micro Invasive Glaucoma Surgery MIGS Devices Market Analysis by types is segmented into:

  • MIGS Stents
  • MIGS Shunts
  • Others

Get a Sample PDF of the Report: https://www.reportprime.com/enquiry/request-sample/9730

The Micro Invasive Glaucoma Surgery MIGS Devices Market Industry Research by Application is segmented into:

  • Hospital
  • Ophthalmology Clinics
  • Ambulatory Surgery Centers (ASCS)
  • Others

In terms of Region, the Micro Invasive Glaucoma Surgery MIGS Devices Market Players available by Region are:

North America:

  • United States
  • Canada

Europe:

  • Germany
  • France
  • U.K.
  • Italy
  • Russia

Asia-Pacific:

  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia

Latin America:

  • Mexico
  • Brazil
  • Argentina Korea
  • Colombia

Middle East & Africa:

  • Turkey
  • Saudi
  • Arabia
  • UAE
  • Korea

Purchase this Report: https://www.reportprime.com/checkout?id=9730&price=3590

Key Drivers and Barriers in the Micro Invasive Glaucoma Surgery MIGS Devices Market

Key drivers in the Micro Invasive Glaucoma Surgery (MIGS) Devices market include increasing prevalence of glaucoma, technological advancements in MIGS devices, and growing adoption of minimally invasive surgical procedures. Additionally, rising awareness about the benefits of MIGS devices and favorable reimbursement policies are also driving market growth.

Barriers in the MIGS Devices market include high cost of devices, limited availability of skilled professionals, and stringent regulatory approval processes. Lack of awareness among patients and healthcare providers about MIGS devices and competition from traditional glaucoma surgeries are also hindering market growth.

Challenges faced in the market include the need for continuous innovation to improve the effectiveness and safety of MIGS devices, addressing cost concerns to enhance accessibility, and overcoming the resistance to change from healthcare providers accustomed to traditional glaucoma treatments. Additionally, the impact of the COVID-19 pandemic on healthcare systems and the economy poses a significant challenge for market growth.

Inquire or Share Your Questions If Any Before Purchasing This Report: https://www.reportprime.com/enquiry/pre-order/9730

Competitive Landscape

Glaukos Corporation is a prominent player in the competitive Micro Invasive Glaucoma Surgery (MIGS) Devices market. The company was founded in 1998 and is headquartered in San Clemente, California. Glaukos specializes in the development and commercialization of novel glaucoma treatment options, including its flagship iStent product which is the smallest medical device ever approved by the FDA.

Another key player in the MIGS Devices market is Allergan, a global pharmaceutical company with a strong presence in the ophthalmology sector. Allergan offers a range of MIGS devices aimed at improving patient outcomes and reducing the need for traditional glaucoma surgeries.

According to market research reports, the global MIGS Devices market is expected to witness significant growth in the coming years due to factors such as the increasing prevalence of glaucoma, technological advancements in surgical procedures, and growing demand for minimally invasive treatment options. The market size is projected to reach billions of dollars by 2025.

In terms of sales revenue, Glaukos Corporation reported revenues of over $350 million in 2020, showcasing its strong market presence and financial performance. Allergan, on the other hand, reported revenues of more than $16 billion in 2020, reflecting its diversified product portfolio and global reach in the healthcare industry.

Overall, the competitive landscape of the MIGS Devices market is characterized by intense competition among key players such as Glaukos Corporation, Allergan, and other leading companies striving to gain a competitive edge through product innovation, strategic partnerships, and expansion into emerging markets.

Purchase this Report: https://www.reportprime.com/checkout?id=9730&price=3590

Get a Sample PDF of the Report: https://www.reportprime.com/enquiry/request-sample/9730

 

Check more reports on reportprime.com